Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
wve-210201 (2 trials)
wve-003 (1 trial)
wve-004 (2 trials)
wve-120101 (2 trials)
wve-120102 (2 trials)
wve-n531 (1 trial)
Huntington Disease (Phase 2)
Muscular Dystrophies (Phase 3)
Muscular Dystrophy, Duchenne (Phase 3)
Trials (10 total)
Trial APIs (6 total)